Blocking usp15 improves anti-pd-1 therapy effectiveness in colorectal cancer models, suggesting immune response enhancement.
Blocking USP15 augments the anti-PD-1 therapy in CRC Models through MDSCs reprogramming.
No takes yet. Share an insight, caveat, or question.
Han et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: